Evidence map›Paper›PMID 33273801›Full record

ArticleMolecular vision2020

Role of

Suneel Gupta, Lynn M Martin, Nishant R Sinha, Kaitlin E Smith, Prashant R Sinha, Emilee M Dailey, Nathan P Hesemann, Rajiv R Mohan

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Long-Term Tolerability and Safety of AAV5-Id3 Gene Therapy to Eyes.Translational vision science & technology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Corneal stromal repair and regeneration.Progress in retinal and eye research · 2022
    Review
  13. Review
  14. Article
  15. Effects of Regular/Dilute Proparacaine Anesthetic Eye Drops in Combination with Ophthalmic Antibiotics on Corneal Wound Healing.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Suneel GuptaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Lynn M MartinHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Nishant R SinhaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Kaitlin E SmithHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Prashant R SinhaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Emilee M DaileyHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Nathan P HesemannHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Rajiv R MohanHarry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Harry S. Truman Memorial Veterans' Hospital · USUniversity of Missouri · US

Funding

Gene Therapy in the CorneaR01EY017294 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2007 to 2018
$4.3M
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur MustardU01EY031650 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2020 to 2024
$3.7M
Novel approaches for corneal haze/fibrosis eliminationR01EY030774 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2019 to 2022
$1.5M
BLRD VA I01 BX000357BLRD VA IK6 BX005646NEI NIH HHS R01 EY017294NEI NIH HHS R01 EY030774NEI NIH HHS U01 EY031650
6 · The paper itself

Abstract

Purpose: Inhibitor of differentiation (Id) proteins are helix-loop-helix (HLH) transcriptional repressors that modulate a range of developmental and cellular processes, including cell differentiation and cell cycle mobilization. The Methods: Primary human corneal stromal fibroblast (h-CSF) cultures were generated from donor human corneas. Human corneal myofibroblasts (h-CMFs) were produced by growing h-CSF in the presence of TGFβ1 under serum-free conditions. The Results: The results indicate that Id3 overexpression does not alter the cellular phenotype or viability of h-CSFs. Overexpression of the Conclusions: Id3 regulates TGFβ-driven differentiation of h-CSFs and formation of h-CMFs in vitro. Targeted

Indexed as

BiomarkersCell DifferentiationCell ProliferationCell ShapeCell SurvivalCorneal StromaFibroblastsFibrosisGene Expression RegulationHumansInhibitor of Differentiation ProteinsModels, BiologicalMyofibroblastsNeoplasm ProteinsReproducibility of ResultsRNA, MessengerBiomarkersID3 protein, humanInhibitor of Differentiation ProteinsNeoplasm ProteinsRNA, MessengerTransforming Growth Factor beta1

Identifiers

PMID33273801
PMCPMC7700910
OpenAlexW3109909734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.